Form 483

TRUECARE BIOMEDIX Form 483, 2020-03-06

FDA issued a Form 483 to TRUECARE BIOMEDIX on 2020-03-06 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

TRUECARE BIOMEDIX · Balasinor, India · Issued March 6, 2020

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

6 Mar 2020
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Jose O Hernandez

6 Mar 2020
21 CFR 211.180(e)(2)

Items to cover on annual reviews

Cited by Jose O Hernandez

6 Mar 2020
21 CFR 211.188(b)

Batch production and Batch Control Record Requirements

Cited by Jose O Hernandez

Inspected site

TBTRUECARE BIOMEDIXBalasinor, India

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.188(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere